Patent US584750A successfully refreshed from Google Patents.
Patent US5325488A successfully refreshed from Google Patents.
Patent FR1108992A successfully refreshed from Google Patents.
Patent US1472047A successfully refreshed from Google Patents.
Patent US4338439A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4338439A Expired / Lapsed US ⏱️ 0.0 years remaining

7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins

Assignee: Eli Lilly and Co
•
Filing: 1978-12-07
•
Granted: 1982-07-06
•
Expires: 1998-12-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Cephalosporin antibiotics of the formula ##STR1## wherein R is cyclohexadienyl, phenyl or substituted phenyl, 2-thienyl, 3-thienyl, 2-furyl or 3-furyl; R 1 is a substituted phenyl having 1 to 4 hydroxy substituents or 1 to 3 amino substituents; and wherein Q is halo, methoxy, methyl or a group of the formula --CH 2 R 2 wherein R 2 is alkanoyloxy, carbamoyloxy, alkoxy, halo, pyridinium or substituted pyridinium or a group of the formula --SR 3 wherein R 3 is alkyl, phenyl, substituted phenyl or a 5 or 6 membered-heteroaryl group having from 1 to 4 heteroatoms selected from the group consisting of O, S, and N; are highly active broad spectrum antibiotics especially useful in the treatment of infections attributable to the gram-negative microorganisms.

Inventors

  • 👤 David K. Herron
  • 👤 William H. W. Lunn

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 02:21
CPC Classifications
C; C07; C07D; C07D501/00; C07D501/14; C07D501/16; C07D501/20; C07D501/59

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 225 words
A compound of the formula ##STR75## wherein Q is methyl or a group of the formula --CH 2 R 2 whereiin R 2 is (a) C 2 -C 4 alkanoyloxy; (b) C 1 -C 4 alkoxy; or (c) pyridinium or monosubstituted pyridinium wherein the substituent is selected from the group consisting of C 1 -C 4 alkyl, halo, hydroxy, hydroxymethyl, trifluoromethyl, carbamoyl, C 1 -C 4 alkylcarbamoyl, carboxy, cyano, and acetyl; and R is cyclohexadienyl, phenyl or phenyl substituted with 1 or 2 groups selected from the group consisting of C 1 -C 4 alkyl, C 1 -C 4 alkoxy, halo, hydroxy, protected hydroxy, nitro, cyano, methanesulfonamido and trifluoromethyl; or R is 2-thienyl, 3-thienyl, 2-furyl or 3-furyl; and R 1 is a group of the formula ##STR76## wherein X is 1, 2, or 3, and y is 1 or 2, and wherein A is substituent selected from the group consisting of hydrogen, halo, C 1 -C 4 alkoxy, amino, protected amino, hydroxy, protected hydroxy, C 1 -C 4 alkyl, nitro, cyano, methanesulfonamido and trifluoromethyl, and R 6 is hydrogen or an amino protecting group; and R 0 is hydrogen, indanyl, phthalidyl or an acyloxymethyl group of the formula ##STR77## wherein Y' is C 1 -C 4 alkyl or phenyl; and when R 0 is hydrogen, the pharmaceutical acceptable nontoxic salts of the acids represented thereby.
Claim 2
Dependent Claim 225 words
A compound of the formula ##STR75## wherein Q is methyl or a group of the formula --CH 2 R 2 whereiin R 2 is (a) C 2 -C 4 alkanoyloxy; (b) C 1 -C 4 alkoxy; or (c) pyridinium or monosubstituted pyridinium wherein the substituent is selected from the group consisting of C 1 -C 4 alkyl, halo, hydroxy, hydroxymethyl, trifluoromethyl, carbamoyl, C 1 -C 4 alkylcarbamoyl, carboxy, cyano, and acetyl; and R is cyclohexadienyl, phenyl or phenyl substituted with 1 or 2 groups selected from the group consisting of C 1 -C 4 alkyl, C 1 -C 4 alkoxy, halo, hydroxy, protected hydroxy, nitro, cyano, methanesulfonamido and trifluoromethyl; or R is 2-thienyl, 3-thienyl, 2-furyl or 3-furyl; and R 1 is a group of the formula ##STR76## wherein X is 1, 2, or 3, and y is 1 or 2, and wherein A is substituent selected from the group consisting of hydrogen, halo, C 1 -C 4 alkoxy, amino, protected amino, hydroxy, protected hydroxy, C 1 -C 4 alkyl, nitro, cyano, methanesulfonamido and trifluoromethyl, and R 6 is hydrogen or an amino protecting group; and R 0 is hydrogen, indanyl, phthalidyl or an acyloxymethyl group of the formula ##STR77## wherein Y' is C 1 -C 4 alkyl or phenyl; and when R 0 is hydrogen, the pharmaceutical acceptable nontoxic salts of the acids represented thereby.
Claim 3
Dependent Claim 26 words
The compound of claim 1 wherein Q is a group of the formula --CH 2 R 2 wherein R 2 is C 2 -C 4 alkanoyloxy.
Claim 4
Dependent Claim 23 words
The compound of claim 1 or claim 2 wherein R o is hydrogen and R 1 is a group of the formula ##STR78##
Claim 5
Dependent Claim 23 words
The compound of claim 1 or claim 2 wherein R o is hydrogen and R 1 is a group of the formula ##STR79##
Claim 6
Dependent Claim 9 words
The compound of claim 1 wherein Q is methyl.
Claim 7
Dependent Claim 18 words
The compound of claim 1 wherein Q is a group of the formula --CH 2 R 2 .
Claim 8
Dependent Claim 10 words
The compound of claim 6 wherein R 2 is acetoxy.
Claim 9
Dependent Claim 10 words
The compound of claim 6 wherein R 2 is methoxy.
Claim 10
Dependent Claim 13 words
The compound of claim 6 wherein R 2 is pyridinium or substituted pyridinium.
Claim 11
Dependent Claim 19 words
The compound of claim 6 wherein R 1 is a group of the formula ##STR80## wherein A is hydrogen.
Claim 12
Dependent Claim 39 words
The compound of claim 10 wherein R 1 is a group of the formula ##STR81## wherein X is 2 or 3 and wherein at least two of the hydroxy substituents are bonded to the phenyl at adjacent carbon atoms.
Claim 13
Dependent Claim 15 words
The compound of claim 11 wherein R is phenyl, 3-hydroxyphenyl, 4-hydroxyphenyl, 3-methanesulfonamidophenyl, 2-thienyl or 1,4-cyclohexadienyl.
Claim 14
Dependent Claim 11 words
The compound of claim 12 wherein R is phenyl or 4-hydroxyphenyl.
Claim 15
Dependent Claim 13 words
The compound of claim 13 wherein R 1 is 2,3-dihydroxyphenyl, 3,4-dihydroxyphenyl, or 3,4,5-trihydroxyphenyl.

References Cited (Backward Citations)

US3982011A Cited
BE828933A Cited
DE2520561A1 Cited
BE833063A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-07-05 1986-01-04 1986-07-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-07-05 1990-01-04 1990-07-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-07-05 1994-01-04 1994-07-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag